Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy
- 1 August 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 54 (2), 618-626
- https://doi.org/10.1046/j.1523-1755.1998.00027.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effectsAmerican Journal of Kidney Diseases, 1997
- Myocardial Hypertrophy in Chronic Renal Failure: A Multifactorial, Reversible AlterationPublished by S. Karger AG ,1995
- Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular HypertrophyNew England Journal of Medicine, 1994
- Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapyKidney International, 1993
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Left Ventricular Dysfunction in End-Stage Renal Disease: Echocardiographic InsightsPublished by Springer Nature ,1992
- Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic PatientsNephrology Dialysis Transplantation, 1991
- Blood Pressure Control in Chronic Dialysis PatientsPublished by Springer Nature ,1989
- Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.Proceedings of the National Academy of Sciences, 1988
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986